SAMH
MIST icon

Shanda Asset Management Holdings’s Milestone Pharmaceuticals MIST Stock Holding History

Shanda Asset Management Holdings’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26,000
Closed -$98K – 84
2020
Q2 		$98K Buy
+26,000
New +$83.8K 0.01% 97

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Shanda Asset Management Holdings's MIST Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of Milestone Pharmaceuticals (MIST) in Q3 2020, closing a stake of 26,000 shares — an estimated $98K sold.

Shanda Asset Management Holdings first reported a position in MIST in Q2 2020 and held it in 1 quarter. The position peaked at $98K in Q2 2020. 31 funds tracked by Wall St. Rank hold MIST as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining Milestone Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 26,000 Milestone Pharmaceuticals shares in Q3 2020, an estimated $98K.
  • Shanda Asset Management Holdings first reported a position in Milestone Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's Milestone Pharmaceuticals position peaked at $98K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.